View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 600 / Trastuzumab 600 / Nab-Paclitaxel 125, Breast Cancer, Cycle 2+
Protocol-ID: 1757 V1.1 (Mini), PERT600/TRAS600/NPAC125, Breast Ca, C2+Indication(s)
- Breast Cancer (HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 26.01.2024